Tag: Complement Inhibition Therapy
Apellis’ APL-2 Injection: Advanced Complement System Modulation for Effective Dry Age-Related...
Dry age-related macular degeneration (AMD) represents a significant and growing cause of visual impairment worldwide, with millions of individuals progressing from early stages of...
